Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not use a separate syringe at all. Each pen is a pre-filled KwikPen holding four weekly doses, so the needle gauge and injection mechanics are built in from the start — there is nothing to draw up, measure or assemble. If you have arrived here wondering which syringe to buy alongside your Mounjaro prescription, the short answer is that you do not need one. The pen handles everything. What does matter, and what often gets overlooked, is understanding exactly how the pen delivers the medicine and what that means for your injection routine. These are prescription-only medicines; a clinical assessment is required before any treatment is supplied.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear fairly regularly, usually from people who have experience with insulin pens or older injectable medicines where you attach a separate needle tip. Mounjaro is different. The KwikPen is a single-use, pre-filled auto-injector: the needle mechanism is integral to the pen, and the medicine is already loaded at the correct dose. If you are curious about how the Mounjaro syringe question actually gets answered, the short version is that there is no vial, no separate syringe, and no measuring. You press the pen against clean skin, activate it, and the injection is complete in a matter of seconds.
The NHS patient information for tirzepatide confirms that Mounjaro is supplied as a ready-to-use subcutaneous injection device. Subcutaneous means the medicine goes into the layer of fatty tissue just beneath the skin, not into muscle. The needle is deliberately short and fine to target that layer comfortably. Eli Lilly designed the KwikPen so that the depth and angle are pre-set, another reason a separate syringe would be the wrong tool entirely.
If you are researching what kind of syringes are used with Mounjaro because you are considering compounded tirzepatide or vials from an unlicensed source, it is worth knowing that these are not approved products under UK law. The licensed medicine comes in the KwikPen format only.
Eli Lilly does not publish a single universal needle gauge for the KwikPen in the way that standalone pen-needle products do, because the needle is integral and not interchangeable. What the NHS tirzepatide page and the Mounjaro Summary of Product Characteristics (SmPC) both confirm is that the device is designed for subcutaneous injection, which in practice means a very fine gauge needle (typically in the 29–32 gauge range for this class of device) and a short insertion depth, usually 4–5 mm.
These specifications exist to make the injection as comfortable as possible while reaching the subcutaneous layer reliably. Because you cannot change the needle on a KwikPen, there is no clinical decision for you to make about gauge or length, that has been made by the device engineers and the prescribing clinician when they chose this delivery format. What you can control is injection site rotation, which genuinely reduces localised discomfort over time. The approved sites are the abdomen (avoiding a few centimetres around the navel), the front of the thigh, and the outer upper arm.
For a broader look at how the pen format fits into treatment, the tirzepatide overview covers the mechanism and licensed strengths in detail.
It is completely understandable to be confused here. Searches for "Mounjaro syringe size" often come from people who are new to injectable medicines and want to feel prepared before their first dose, people comparing Mounjaro with older GLP-1 treatments that used detachable pen needles, or people who have seen social media posts about drawing tirzepatide from a vial. All of those are legitimate starting points.
The reassuring reality is that the KwikPen removes most of the technical anxiety. There is no drawing-up, no air-bubble check, no gauge selection. The NHS tirzepatide guidance and the MHRA-approved Patient Information Leaflet walk through the injection steps clearly, and your prescriber or clinical team should confirm the process at the point of approval. If you are looking at treatment options and wondering how the different Mounjaro strengths map to the titration schedule, that is a separate but related question worth exploring.
One thing worth flagging: if you have come across sellers offering tirzepatide in vial form alongside instructions to draw it into a syringe, our guide to the best syringes for tirzepatide explains why those products are not licensed Mounjaro and what the risks are. The MHRA has warned publicly about illegally traded weight-loss medicines, including counterfeit pens and unlicensed preparations, report any suspect sellers at the MHRA Yellow Card site.
Not clinically. The medicine itself (tirzepatide, a dual GIP and GLP-1 receptor agonist) behaves the same way regardless of the delivery device. The KwikPen format is a practical design choice, not a pharmacological one. Once injected into the subcutaneous tissue, tirzepatide is absorbed gradually over the week, which is why dosing is once weekly rather than daily.
What the pen format does change is the practical experience. Compared with devices that require needle attachment, the KwikPen has fewer steps, which means fewer opportunities for technique errors. For most people, injection anxiety settles quickly once they have completed their first or second dose. The Mounjaro treatment page has more on what to expect across a typical course.
If you are at the stage of considering whether Mounjaro might be right for you, the process starts with a clinical consultation rather than a device decision. You can check your eligibility with our prescribers at no charge, a real clinician reviews every consultation the same day, and the device and dose are confirmed as part of that clinical assessment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.